mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |